Menu
GeneBe

UNG

uracil DNA glycosylase, the group of DNA glycosylases

Basic information

Region (hg38): 12:109097596-109126725

Previous symbols: [ "DGU" ]

Links

ENSG00000076248NCBI:7374OMIM:191525HGNC:12572Uniprot:P13051AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hyper-IgM syndrome type 5 (Strong), mode of inheritance: AR
  • hyper-IgM syndrome type 5 (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Immunodeficiency with hyper-IgM, type 5ADAllergy/Immunology/InfectiousDue to low/absent serum IgG, IgA, and IgE, Individuals are susceptible to recurrent/severe bacterial infections, and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficialAllergy/Immunology/Infectious12958596; 15358621

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the UNG gene.

  • Hyper-IgM syndrome type 5 (214 variants)
  • not provided (26 variants)
  • Inborn genetic diseases (11 variants)
  • Hyperimmunoglobulin M syndrome (4 variants)
  • not specified (3 variants)
  • Hereditary breast ovarian cancer syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the UNG gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
38
clinvar
3
clinvar
45
missense
82
clinvar
4
clinvar
1
clinvar
87
nonsense
2
clinvar
2
clinvar
4
start loss
0
frameshift
8
clinvar
1
clinvar
1
clinvar
10
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
5
1
6
non coding
30
clinvar
30
clinvar
17
clinvar
77
Total 10 3 122 72 21

Highest pathogenic variant AF is 0.000164

Variants in UNG

This is a list of pathogenic ClinVar variants found in the UNG region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-109097607-C-T Hyper-IgM syndrome type 5 Uncertain significance (Jan 13, 2018)306963
12-109097629-A-G Hyper-IgM syndrome type 5 Uncertain significance (Apr 27, 2017)884163
12-109097629-A-T Hyper-IgM syndrome type 5 Uncertain significance (Jan 12, 2018)306964
12-109097630-G-A Hyper-IgM syndrome type 5 Uncertain significance (Jan 12, 2018)884164
12-109097685-C-A Hyper-IgM syndrome type 5 Uncertain significance (Jan 12, 2018)306965
12-109097693-A-G Hyper-IgM syndrome type 5 Uncertain significance (Sep 03, 2020)1059502
12-109097695-A-G Uncertain significance (Sep 09, 2021)1694079
12-109097711-T-C Hyper-IgM syndrome type 5 • not specified Uncertain significance (Oct 26, 2022)947219
12-109097713-T-A Hyper-IgM syndrome type 5 Uncertain significance (Jul 12, 2021)1374478
12-109097713-TC-T Hyper-IgM syndrome type 5 Pathogenic (Jan 15, 2022)2083377
12-109097713-TCCCCCAGCCCCGCCAGGAAGCGACACG-T Hyper-IgM syndrome type 5 Uncertain significance (Jan 06, 2021)1347471
12-109097715-C-A Hyper-IgM syndrome type 5 Conflicting classifications of pathogenicity (Nov 16, 2023)884165
12-109097715-C-T Hyper-IgM syndrome type 5 Likely benign (Aug 04, 2023)1132218
12-109097739-C-T Hyper-IgM syndrome type 5 Likely benign (Nov 13, 2023)2695556
12-109097740-G-A Hyper-IgM syndrome type 5 • not specified Uncertain significance (May 20, 2023)643750
12-109097741-C-T Hyper-IgM syndrome type 5 Uncertain significance (Apr 08, 2021)1369721
12-109097744-C-T Hyper-IgM syndrome type 5 Uncertain significance (Jul 14, 2022)880878
12-109097755-C-T Hyper-IgM syndrome type 5 Uncertain significance (Feb 24, 2021)1425612
12-109097756-C-A Hyper-IgM syndrome type 5 Uncertain significance (Mar 07, 2022)1975332
12-109097760-C-A Hyper-IgM syndrome type 5 Conflicting classifications of pathogenicity (Oct 06, 2023)306966
12-109097765-A-C Hyper-IgM syndrome type 5 Uncertain significance (Feb 10, 2022)880879
12-109097769-G-A Hyper-IgM syndrome type 5 Likely benign (Nov 28, 2023)1943735
12-109097769-G-T Hyper-IgM syndrome type 5 Likely benign (Oct 14, 2023)1364710
12-109097779-G-A Hyper-IgM syndrome type 5 Uncertain significance (Jan 12, 2018)306967
12-109097784-G-A Hyper-IgM syndrome type 5 Likely benign (Dec 01, 2023)2167146

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
UNGprotein_codingprotein_codingENST00000242576 713419
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.001720.9751257010471257480.000187
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.05601731750.9880.000008712031
Missense in Polyphen4854.8730.87475678
Synonymous-1.699071.81.250.00000379609
Loss of Function2.00715.50.4527.44e-7178

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001050.000952
Ashkenazi Jewish0.0005000.000496
East Asian0.0002180.000217
Finnish0.00004620.0000462
European (Non-Finnish)0.0001520.000132
Middle Eastern0.0002180.000217
South Asian0.0001960.000196
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Excises uracil residues from the DNA which can arise as a result of misincorporation of dUMP residues by DNA polymerase or due to deamination of cytosine.;
Disease
DISEASE: Immunodeficiency with hyper-IgM 5 (HIGM5) [MIM:608106]: A rare immunodeficiency syndrome characterized by normal or elevated serum IgM levels with absence of IgG, IgA, and IgE. It results in a profound susceptibility to bacterial infections. {ECO:0000269|PubMed:12958596, ECO:0000269|PubMed:15967827}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Primary immunodeficiency - Homo sapiens (human);Base excision repair - Homo sapiens (human);DNA Repair;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites);Base Excision Repair;Displacement of DNA glycosylase by APEX1 (Consensus)

Recessive Scores

pRec
0.456

Intolerance Scores

loftool
0.745
rvis_EVS
-0.47
rvis_percentile_EVS
23.25

Haploinsufficiency Scores

pHI
0.569
hipred
Y
hipred_score
0.682
ghis
0.613

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.995

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ung
Phenotype
immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); neoplasm; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype;

Zebrafish Information Network

Gene name
unga
Affected structure
whole organism
Phenotype tag
abnormal
Phenotype quality
deformed

Gene ontology

Biological process
DNA repair;base-excision repair;viral process;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;negative regulation of apoptotic process;depyrimidination;positive regulation of isotype switching;base-excision repair, AP site formation via deaminated base removal
Cellular component
nucleus;nucleoplasm;mitochondrion
Molecular function
damaged DNA binding;uracil DNA N-glycosylase activity;protein binding;ribosomal small subunit binding